The Effect of Human Urinary Kallikrein on Corticospinal Tract Injury in Acute Ischemia Stroke Patients

2019-09-30 07:06:55 | BioPortfolio


Acute cerebral infarction is a common type of ischemic stroke, causing brain dysfunction in patients with high morbidity and disability. With the changes in people's diet, lifestyle patterns and population aging, the incidence of acute cerebral infarction has increased year by year, which has become an important cause of disability and death in middle-aged and elderly patients. Therefore, it is of great significance to society and individuals to carry out in-depth research on new ideas for the treatment of cerebral infarction and to reduce the disability and mortality of patients.Acute cerebral infarction leads to damage of the corticospinal tract, which can cause severe limb paralysis, seriously affecting the patients' prognosis and daily activities, and imposing a heavy burden on the patients' family and society.According to current research, TK plays a neuroprotective role in ischemic and hypoxic brain cells, and promotes the survival of nerve cells and improves the prognosis of patients with clinical ischemic stroke. Kallikrein is a human urokininogenase, which has been proven to be effective in acute ischemic stroke. Kallikrein can selectively dilate the arterioles in the ischemic area through the kallikrein-kinin system (KKS), reduce the infarct size, increase the density of blood vessels around the infarct, improve collateral circulation, and significantly improve the symptoms of neurological deficits in patients. However, to date, there is no direct evidence that Kallikrein can mediate neuroprotection and regeneration under conditions of ischemic injury.

In this study, the investigators used primary cortical neuronal cells of CD-1 mice treated with ischemia and hypoxia, C57 black mice with MCAO, and patients with clinical acute ischemic stroke to try to prove the effect of Kallikrein's direct evidence on neuroprotection and regeneration of acute ischemic injury.


The investigators collected 80 patients with acute cerebral infarction from July 2007 to March 2019 in the Department of Neurology, Second Hospital of Hebei Medical University. They were randomly divided into Kallikrein+standard treatment group and standard treatment group. And both groups were treated for 14 ± 5 days. Blood samples were collected from patients within 3 days of onset and after 14±5 days of treatment. Serum nerve growth markers NEFH, MBP, and VEGF were detected by ELISA, and two diffusion tensor imaging (DTI) scans were performed. Growth markers and imaging indicators FA and ADC values were used to evaluate the effect of Kallikrein on motor function recovery in clinical patients.

Study Design


Stroke, Acute




Second hospital of hebei medical university




The Second Hospital of Hebei Medical University

Results (where available)

View Results


Published on BioPortfolio: 2019-09-30T07:06:55-0400

Clinical Trials [2170 Associated Clinical Trials listed on BioPortfolio]

The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein

In order to reevaluate safety and efficacy of human urinary kallikrein in treating acute cerebral infarction ,a multi-center, open label , single group study was designed. Expect to enroll...

Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients

Urinary kallikrein excretion is known to increase in patients with nephrotic syndrome and sick cell disease, but decrease in patients with chronic kidney disease or uremia. Some of authors...

The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship

Evaluate the effectiveness of the of kallikrein in the different drug frequency for acute anterior circulation cerebral infarction.

Urinary Kallikrein and Hypertension: A Prospective Study

To determine whether low total urinary kallikrein activity was prospectively associated with new hypertension onset or elevated blood pressures.

Exploring Motor Learning in Acute Stroke Through Robotics

The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor ski...

PubMed Articles [7575 Associated PubMed Articles listed on BioPortfolio]

Do acute stroke patients develop hypocapnia? A systematic review and meta-analysis.

Carbon dioxide (CO) is a potent cerebral vasomotor agent. Despite reduction in CO levels (hypocapnia) being described in several acute diseases, there is no clear data on baseline CO values in acute s...

Plasma CLEC-2 as a Predictor of Death and Vascular Events in Patients with Acute Ischemic Stroke.

CLEC-2 is a C-type lectin-like receptor with the prominent involvement in platelet activation, which was increased in coronary heart disease (CHD) and acute ischemic stroke (AIS) and was associated wi...

A DS Score to Predict the Risk of Stroke-Associated Pneumonia in Acute Stroke: An Indian Perspective.

 Stroke-associated pneumonia (SAP) is an important cause of poststroke morbidity and mortality. Several clinical risk scores predict the risk of SAP. In this study, we used the A DS score (age, at...

Cardiac Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke and Elevated Troponin: A TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Sub-Study.

Elevated high-sensitive cardiac troponin (hs-cTn) can be found in more than 50% of the patients with acute ischemic stroke. The observational TRoponin ELevation in Acute ischemic Stroke (TRELAS) study...

The outcomes of statin therapy in patients with acute ischemic stroke in Taiwan: A nationwide epidemiologic study.

Acute stroke is the third leading cause of death in Taiwan. Although statin therapy is widely recommended for stroke prevention, little is known about the epidemiology of statin therapy after acute is...

Medical and Biotech [MESH] Definitions

Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein (with cofactor HIGH MOLECULAR WEIGHT KININOGEN) cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments (Hageman-Factor fragments). These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.

Restoration of functions to the maximum degree possible in a person or persons suffering from a stroke.

Sudden death from overwork, most often as a result of acute CARDIOVASCULAR STROKE.

Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC, TISSUE KALLIKREIN (EC, and PROSTATE-SPECIFIC ANTIGEN (EC

Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.

More From BioPortfolio on "The Effect of Human Urinary Kallikrein on Corticospinal Tract Injury in Acute Ischemia Stroke Patients"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...

Searches Linking to this Trial